Physician profile
Gregory Young
NPI 1790727691
$1,312.79
in general payments reported to CMS, 2019-2025
19 companies · $196 in 2025
The $196 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $255 · 2020: $162 · 2021: $152 · 2022: $280 · 2023: $155 · 2024: $113 · 2025: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $463.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $330.67 | 2020-2025 | Dupixent |
| Neurent Medical Limited | $163.15 | 2022 | |
| Optinose US, INC. | $142.98 | 2019-2024 | |
| Acclarent, INC | $131.54 | 2019-2023 | Acclarent Aera |
| Glaxosmithkline, LLC. | $104.79 | 2023-2025 | Nucala |
| Sanofi-Aventis U.S. LLC | $97.17 | 2019-2021 | |
| Genzyme Corporation | $53.06 | 2023-2025 | |
| Kaleo, INC. | $44.08 | 2020 | |
| Intersect Ent, INC. | $38.40 | 2020 | |
| Alk-Abello, INC | $30.02 | 2020-2021 | |
| Axogen | $28.46 | 2025 | |
| Novartis Pharmaceuticals Corporation | $21.25 | 2019 | |
| Stryker Corporation | $21.01 | 2025 | Scopis Ent |
| Aerin Medical INC. | $20.44 | 2022 | |
| Fortovia Therapeutics, INC. | $20.22 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Masimo Corporation | $19.10 | 2021 | |
| Ethicon US, LLC | $18.06 | 2019 | |
| Merck Sharp & Dohme LLC | $15.35 | 2021 | |
| Hikma Pharmaceuticals USA | $13.04 | 2023 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.